<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39434179</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1745-6215</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>22</Day></PubDate></JournalIssue><Title>Trials</Title><ISOAbbreviation>Trials</ISOAbbreviation></Journal><ArticleTitle>Telehealth-delivered cognitive rehabilitation for people with cognitive impairment as part of the post-COVID syndrome: protocol for a randomised controlled trial as part of the CICERO (Cognitive Impairment in Long COVID: Phenotyping and Rehabilitation) study.</ArticleTitle><Pagination><StartPage>704</StartPage><MedlinePgn>704</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">704</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13063-024-08554-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Between 25 and 75% of people with persistent post-acute sequelae of SARS-CoV-2 infection (PASC) experience cognitive difficulties, compromising functional ability, quality of life, and activities of daily living, including work. Despite this significant morbidity, there is a paucity of interventions for this disorder that have undergone evaluation within a formal trial setting. Therefore, we have developed a cognitive rehabilitation programme, specifically designed to address the cognitive symptoms of PASC, notably impaired attention and processing speed, while also accounting for other PASC symptoms (fatigue, post-exertional malaise) that may aggravate the cognitive impairment. This study protocol outlines a randomised controlled trial (RCT) designed to evaluate the effectiveness of this programme compared to standard clinical care.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a multi-centre, parallel-group, individually randomised controlled trial, comparing standard clinical care with and without cognitive rehabilitation. We will recruit 120 non-hospitalised adults (aged 30-60&#xa0;years) from three NHS sites in England with a history of COVID-19 infection and cognitive impairment persisting more than 3&#xa0;months after the acute infection. Participants will be randomised (1:1) to the intervention or control groups, with the latter represented as a provision of standard clinical care without cognitive rehabilitation. The cognitive rehabilitation programme consists of ten 1-hour sessions, delivered weekly. Outcomes will be collected at baseline, 3, and 6&#xa0;months, with participant-defined goal-attainment scores, relating to functional goals, at 3&#xa0;months as the primary outcome measure. Secondary outcomes will be cognitive function, measures of quality of life, social functioning, mental health, fatigue, sleep, post-exertional malaise, and social and health care service use. We will also evaluate the health-economic benefits of cognitive rehabilitation in this population.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Cognitive impairment in PASC is a major cause of functional disability with no effective treatment. Accordingly, we will undertake an RCT of cognitive rehabilitation, the protocol of which is published here. If this trial is successful in delivering improvements in trial outcomes, it will address a major unmet need relating to this emergent disorder, with a significant impact on affected individuals and the wider health economy.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov NCT05731570. Registered on February 16, 2023.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vanova</LastName><ForeName>Martina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1329-7566</Identifier><AffiliationInfo><Affiliation>Dementia Research Centre, Faculty of Brain Sciences, UCL Queen Square Institute of Neurology, University College London, London, UK. m.vanova@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Aysha Mohamed Rafik</ForeName><Initials>AMR</Initials><Identifier Source="ORCID">0009-0004-4987-8217</Identifier><AffiliationInfo><Affiliation>Institute of Cognitive Neuroscience, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Iona</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Cognitive Neuroscience, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilpin</LastName><ForeName>Gina</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-9441-7979</Identifier><AffiliationInfo><Affiliation>Institute of Cognitive Neuroscience, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manning</LastName><ForeName>Emily N</ForeName><Initials>EN</Initials><Identifier Source="ORCID">0000-0002-4505-3611</Identifier><AffiliationInfo><Affiliation>Institute of Cognitive Neuroscience, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ash</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0007-2591-9637</Identifier><AffiliationInfo><Affiliation>Institute of Cognitive Neuroscience, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wittenberg</LastName><ForeName>Philippa</ForeName><Initials>P</Initials><Identifier Source="ORCID">0009-0003-8583-7896</Identifier><AffiliationInfo><Affiliation>Institute of Cognitive Neuroscience, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Jason</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6397-3131</Identifier><AffiliationInfo><Affiliation>School of Applied Sciences, University of Brighton, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoare</LastName><ForeName>Zoe</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-1803-5482</Identifier><AffiliationInfo><Affiliation>North Wales Medical School, Bangor University, Bangor, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0960-9843</Identifier><AffiliationInfo><Affiliation>North Wales Medical School, Bangor University, Bangor, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bray</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-7646-5435</Identifier><AffiliationInfo><Affiliation>School of Health Sciences, Bangor University, Bangor, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kipps</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0002-5205-9712</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Southampton NHS Trust, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devine</LastName><ForeName>Ciara</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0008-9107-1045</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Southampton NHS Trust, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Saliha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>GM Dementia Research Centre, Greater Manchester Mental Health NHS Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunne</LastName><ForeName>Ross</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>GM Dementia Research Centre, Greater Manchester Mental Health NHS Trust, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geoffery Jefferson Brain Research Centre, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koniotes</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0000-7009-6456</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Sussex NHS Trust, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warren</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0002-0119-820X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Sussex NHS Trust, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chan</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-4265-3718</Identifier><AffiliationInfo><Affiliation>Institute of Cognitive Neuroscience, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Sussex NHS Trust, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Suarez-Gonzalez</LastName><ForeName>Aida</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0904-1031</Identifier><AffiliationInfo><Affiliation>Dementia Research Centre, Faculty of Brain Sciences, UCL Queen Square Institute of Neurology, University College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05731570</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trials</MedlineTA><NlmUniqueID>101263253</NlmUniqueID><ISSNLinking>1745-6215</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="N">Telemedicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069350" MajorTopicYN="N">Telerehabilitation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015928" MajorTopicYN="N">Cognitive Behavioral Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000091942" MajorTopicYN="N">Cognitive Training</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cognitive rehabilitation</Keyword><Keyword MajorTopicYN="N">Post-acute sequele of SARS-COV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>7</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>23</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39434179</ArticleId><ArticleId IdType="pmc">PMC11494741</ArticleId><ArticleId IdType="doi">10.1186/s13063-024-08554-3</ArticleId><ArticleId IdType="pii">10.1186/s13063-024-08554-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020Oct;7(10):875&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020Jul;7(7):611&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020Jun 4;382(23):2268&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Vakani K, Ratto M, Sandford-James A, Antonova E, Kumari V. COVID-19 and cognitive function: evidence for increased processing speed variability in COVID-19 survivors and multifaceted impairment with long-COVID symptoms. Eur Psychiatry. 2023May 12;66(1): e43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10305372</ArticleId><ArticleId IdType="pubmed">37170616</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham EJ, Chou SHY, Coles AJ, Menon DK. Neurological implications of COVID-19 infections. Neurocrit Care. 2020Jun 28;32(3):667&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7188454</ArticleId><ArticleId IdType="pubmed">32346843</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeria M, Cejudo JC, Sotoca J, Deus J, Krupinski J. Cognitive profile following COVID-19 infection: clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health. 2020Dec;9: 100163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7581383</ArticleId><ArticleId IdType="pubmed">33111132</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020Jun 1;77(6):683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021Sep;39: 101044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Loft MI, Foged EM, Koreska M. An unexpected journey: the lived experiences of patients with long-term cognitive sequelae after recovering from COVID-19. Qual Health Res. 2022Jul 21;32(8&#x2013;9):1356&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9124947</ArticleId><ArticleId IdType="pubmed">35603563</ArticleId></ArticleIdList></Reference><Reference><Citation>Lades LK, Laffan K, Daly M, Delaney L. Daily emotional well-being during the COVID-19 pandemic. Br J Health Psychol. 2020Nov 23;25(4):902&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361840</ArticleId><ArticleId IdType="pubmed">32573074</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira AK, Nogueira Alves IG, de Queiroz RS, de Castro MR, Gomes VA, Santos Fontoura FC, et al. A systematic review on physical function, activities of daily living and health-related quality of life in COVID-19 survivors. Chronic Illn. 2023Jun 11;19(2):279&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9006095</ArticleId><ArticleId IdType="pubmed">35404175</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorenzato E, Zabberoni S, Costa A, Cona G. Cognitive and mental health changes and their vulnerability factors related to COVID-19 lockdown in Italy. PLoS ONE. 2021Jan 27;16(1): e0246204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7840042</ArticleId><ArticleId IdType="pubmed">33503055</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehtisalo J, Palmer K, Mangialasche F, Solomon A, Kivipelto M, Ngandu T. Changes in lifestyle, behaviors, and risk factors for cognitive impairment in older persons during the first wave of the coronavirus disease 2019 pandemic in Finland: results from the FINGER Study. Front Psychiatry. 2021Feb;12:12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7907420</ArticleId><ArticleId IdType="pubmed">33643095</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizarro-Pennarolli C, S&#xe1;nchez-Rojas C, Torres-Castro R, Vera-Uribe R, Sanchez-Ramirez DC, Vasconcello-Castillo L, et al. Assessment of activities of daily living in patients post COVID-19: a systematic review. PeerJ. 2021Apr;6(9): e11026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8034364</ArticleId><ArticleId IdType="pubmed">33868804</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicerone KD, Langenbahn DM, Braden C, Malec JF, Kalmar K, Fraas M, et al. Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008. Arch Phys Med Rehabil. 2011Apr;92(4):519&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">21440699</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouraeinejad A. A proposal to apply brain injury recovery treatments for cognitive impairment in COVID-19 survivors. Int J Neurosci. 2022Jun;5:1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">35635529</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappa SF, Benke T, Clarke S, Rossi B, Stemmer B, van Heugten CM. EFNS guidelines on cognitive rehabilitation: report of an EFNS task force. Eur J Neurol. 2005Sep 26;12(9):665&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">16128867</ArticleId></ArticleIdList></Reference><Reference><Citation>Rath JF, Simon D, Langenbahn DM, Sherr RL, Diller L. Group treatment of problem-solving deficits in outpatients with traumatic brain injury: a randomised outcome study. Neuropsychol Rehabil. 2003Sep;13(4):461&#x2013;88.</Citation></Reference><Reference><Citation>Levine B, Schweizer TA, O&#x2019;Connor C, Turner G, Gillingham S, Stuss DT, et al. Rehabilitation of executive functioning in patients with frontal lobe brain damage with goal management training. Frontiers Human Neuroscience [Internet]. 2011;5. Available from: http://journal.frontiersin.org/article/10.3389/fnhum.2011.00009/abstract</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3043269</ArticleId><ArticleId IdType="pubmed">21369362</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008Dec;7(12):1139&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">19007738</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien AR, Chiaravalloti N, Goverover Y, DeLuca J. Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature. Arch Phys Med Rehabil. 2008Apr;89(4):761&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18374010</ArticleId></ArticleIdList></Reference><Reference><Citation>Inchausti F, MacBeth A, Hasson-Ohayon I, Dimaggio G. Telepsychotherapy in the age of COVID-19: a commentary. J Psychother Integr. 2020Jun;30(2):394&#x2013;405.</Citation></Reference><Reference><Citation>Poon P, Hui E, Dai D, Kwok T, Woo J. Cognitive intervention for community-dwelling older persons with memory problems: telemedicine versus face-to-face treatment. Int J Geriatr Psychiatry. 2005Mar 16;20(3):285&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">15717335</ArticleId></ArticleIdList></Reference><Reference><Citation>Kever A, Aguerre IM, Vargas W, Straus Farber R, Levine L, Riley CS, et al. Feasibility trial of a telehealth support group intervention to reduce anxiety in multiple sclerosis. Clin Rehabil. 2022Oct 7;36(10):1305&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">35673256</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15e;ahin E, Yavuz Veizi BG, Naharci MI. Telemedicine interventions for older adults: a systematic review. J Telemed Telecare. 2024Feb 26;30(2):305&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">34825609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghadiri F, Naser Moghadasi A, Sahraian MA. Telemedicine as a strategic intervention for cognitive rehabilitation in MS patients during COVID-19. Acta Neurol Belg. 2022Feb 30;122(1):23&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8801040</ArticleId><ArticleId IdType="pubmed">35094365</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashshur RL, Shannon GW, Bashshur N, Yellowlees PM. The empirical evidence for telemedicine interventions in mental disorders. Telemedicine and e-Health. 2016Feb;22(2):87&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4744872</ArticleId><ArticleId IdType="pubmed">26624248</ArticleId></ArticleIdList></Reference><Reference><Citation>Boserup B, McKenney M, Elkbuli A. Disproportionate impact of COVID-19 pandemic on racial and ethnic minorities. Am Surg. 2020Dec 24;86(12):1615&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7691116</ArticleId><ArticleId IdType="pubmed">33231496</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence - NICE. Stroke rehabilitation in adults - clinical guideline [Internet]. 2013. Available from: www.nice.org.uk/guidance/cg162</Citation></Reference><Reference><Citation>Scottish Intercollegiate Guidelines Network. SIGN 130 &#x2022; brain injury rehabilitation in adults [Internet]. 2013. Available from: www.sign.ac.uk.</Citation></Reference><Reference><Citation>Novakovic-Agopian T, Kornblith E, Abrams G, Burciaga-Rosales J, Loya F, D&#x2019;Esposito M, et al. Training in goal-oriented attention self-regulation improves executive functioning in veterans with chronic traumatic brain injury. J Neurotrauma. 2018Dec;35(23):2784&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8104023</ArticleId><ArticleId IdType="pubmed">29717652</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantoni L, Poggesi A, Diciotti S, Valenti R, Orsolini S, Della Rocca E, et al. Effect of attention training in mild cognitive impairment patients with subcortical vascular changes: the RehAtt Study. Journal of Alzheimer&#x2019;s Disease. 2017Sep 18;60(2):615&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5611829</ArticleId><ArticleId IdType="pubmed">28869475</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013 Jan 9;346(jan08 15):e7586&#x2013;e7586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3541470</ArticleId><ArticleId IdType="pubmed">23303884</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz KF. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010Jun 1;152(11):726.</Citation><ArticleIdList><ArticleId IdType="pubmed">20335313</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu AP, Pearse JE, Rapley T. Publishing protocols for trials of complex interventions before trial completion &#x2013; potential pitfalls, solutions and the need for public debate. Trials. 2017Dec 9;18(1):5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5223296</ArticleId><ArticleId IdType="pubmed">28069042</ArticleId></ArticleIdList></Reference><Reference><Citation>Staniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, et al. GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. BMJ. 2017Aug;2: j3453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5539518</ArticleId><ArticleId IdType="pubmed">28768629</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkins JL, Masoli JAH, Delgado J, Pilling LC, Kuo CL, Kuchel GA, et al. Preexisting comorbidities predicting COVID-19 and mortality in the UK Biobank community cohort. The Journals of Gerontology: Series A. 2020Oct 15;75(11):2224&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454409</ArticleId><ArticleId IdType="pubmed">32687551</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O&#x2019;Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019Jul;95: 103208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Clare L, Nelis SM, Kudlicka A. Bangor Goal&#x2010;Setting Interview manual. University of Exeter; 2016. https://medicine.exeter.ac.uk/v8media/facultysites/hls/healthandcommunitysciences/documents/The_Bangor_Goal-Setting_Interview_Version_2.2_Manual_(BGSI_v.2.2)_March_2022.pdf.</Citation></Reference><Reference><Citation>Cotler J, Holtzman C, Dudun C, Jason L. A brief questionnaire to assess post-exertional malaise. Diagnostics. 2018Sep 11;8(3):66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6165517</ArticleId><ArticleId IdType="pubmed">30208578</ArticleId></ArticleIdList></Reference><Reference><Citation>Randolph C, Tierney MC, Mohr E, Chase TN. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol. 1998Jun 9;20(3):310&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9845158</ArticleId></ArticleIdList></Reference><Reference><Citation>Delis DC, Kaplan E, Kramer JH. Delis-Kaplan Executive Function System [Database Record]. APA PsycTests. 2001. 10.1037/t15082-000.</Citation></Reference><Reference><Citation>Wechsler D. WAIS-III: Administration and scoring manual. San Antonio: The Psychological Association; 1997.</Citation></Reference><Reference><Citation>Wechsler D. Test of premorbid functioning. San Antonio, TX: The Psychological Corporation; 2009.</Citation></Reference><Reference><Citation>Anwyl-Irvine AL, Massonni&#xe9; J, Flitton A, Kirkham N, Evershed JK. Gorilla in our midst: an online behavioral experiment builder. Behav Res Methods. 2020Feb 23;52(1):388&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7005094</ArticleId><ArticleId IdType="pubmed">31016684</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess PW, Dumontheil I, Gilbert SJ. The gateway hypothesis of rostral prefrontal cortex (area 10) function. Trends Cogn Sci. 2007Jul;11(7):290&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17548231</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan D, Gallaher LM, Moodley K, Minati L, Burgess N, Hartley T. The 4 Mountains Test: a short test of spatial memory with high sensitivity for the diagnosis of pre-dementia Alzheimer&#x2019;s disease. J Vis Exp. 2016;(116). 10.3791/54454.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5092189</ArticleId><ArticleId IdType="pubmed">27768046</ArticleId></ArticleIdList></Reference><Reference><Citation>Berron D, Ziegler G, Vieweg P, Billette O, G&#xfc;sten J, Grande X, et al. Feasibility of Digital Memory Assessments in an Unsupervised and Remote Study Setting. Front Digit Health. 2022;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9199443</ArticleId><ArticleId IdType="pubmed">35721797</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011Dec 9;20(10):1727&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>McCrone A, Smith A, Hooper J, Parker RA, Peters A. The life-space assessment measure of functional mobility has utility in community-based physical therapist practice in the United Kingdom. Phys Ther. 2019Dec 16;99(12):1719&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6913228</ArticleId><ArticleId IdType="pubmed">31577034</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommerlad A, Singleton D, Jones R, Banerjee S, Livingston G. Development of an instrument to assess social functioning in dementia: the Social Functioning in Dementia scale (SF-DEM). Alzheimer&#x2019;s &amp; Dementia: Diagnosis, Assessment &amp; Disease Monitoring. 2017Jan 23;7(1):88&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5344217</ArticleId><ArticleId IdType="pubmed">28317009</ArticleId></ArticleIdList></Reference><Reference><Citation>Graf C. The Lawton Instrumental Activities of Daily Living Scale. AJN, American Journal of Nursing. 2008Apr;108(4):52&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">18367931</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer RL, Kroenke K, Williams JBW, L&#xf6;we B. A brief measure for assessing generalized anxiety disorder. Arch Intern Med. 2006May 22;166(10):1092.</Citation><ArticleIdList><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Strine TW, Spitzer RL, Williams JBW, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009Apr;114(1&#x2013;3):163&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">18752852</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C. The Chalder Fatigue Scale (CFQ 11). Occup Med (Chic Ill). 2015Jan;65(1):86&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">25559796</ArticleId></ArticleIdList></Reference><Reference><Citation>Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989May;28(2):193&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Beecham J, Knapp M. Costing psychiatric interventions. In: Thornicroft G, editor. Measuring mental health needs. 2nd ed. Gaskell; 2001. p. 200&#x2013;24. ISBN 9781901242607.</Citation></Reference><Reference><Citation>Clare L, Kudlicka A, Oyebode JR, Jones RW, Bayer A, Leroi I, et al. Goal-oriented cognitive rehabilitation for early-stage Alzheimer&#x2019;s and related dementias: the GREAT RCT. Health Technol Assess (Rockv). 2019Mar;23(10):1&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6441850</ArticleId><ArticleId IdType="pubmed">30879470</ArticleId></ArticleIdList></Reference><Reference><Citation>Law M, Baptiste S, McColl M, Opzoomer A, Polatajko H, Pollock N. The Canadian Occupational Performance Measure: An Outcome Measure for Occupational Therapy. Can J Occup Ther. 1990;57(2):82&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10104738</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell D, Hoare ZSJ, Whitaker Rh, Whitaker CJ, Russell IT. Generalized method for adaptive randomization in clinical trials. Stat Med. 2011Apr 30;30(9):922&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">21284014</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones KC, Weatherly H, Chalkley A, Martin, Dargan A, Forder JE. Unit costs of health and social care 2023 manual. 2024; Available from: 10.22024/UniKent/01.02.105685</Citation></Reference><Reference><Citation>Bono C, Ried LD, Kimberlin C, Vogel B. Missing data on the Center for Epidemiologic Studies Depression Scale: a comparison of 4 imputation techniques. Res Social Adm Pharm. 2007Mar;3(1):1&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">17350555</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>